To detect the eEF2K gene expression status in various cancers, we comprehensively screened 7,452 primary tumors and 1,196 normal adjacent-tissue samples spanning 33 cancer or carcinoma types in the TCGA database in the study using the TIMER2 tool (Table 1). Here, EEF2K is linked to cancer.